Streptococcus pneumoniae News and Research

RSS
Streptococcus pneumoniae, or Pneumococcus, is a very common bacterial infection in both industrialized and developing countries. In particular, young children and the elderly represent high-risk populations of developing pneumococcal infections. According to the WHO, the bacterium kills up to one million children under the age of five years each year worldwide. It accounts for many Bacterial Meningitis cases in adults and it is the most common cause of Bacteraemia, Pneumonia, Meningitis and Otitis media in young children.
Paratek Pharmaceuticals and Novartis to collaborate in PTK 0796 broad-spectrum antibiotic development

Paratek Pharmaceuticals and Novartis to collaborate in PTK 0796 broad-spectrum antibiotic development

Rib-X and NIAID collaborate to develop an antibiotic treatment for N. gonorrhoeae

Rib-X and NIAID collaborate to develop an antibiotic treatment for N. gonorrhoeae

AzaSite production increased to combat erythromycin ophthalmic ointment shortage

AzaSite production increased to combat erythromycin ophthalmic ointment shortage

Prevention and treatment of pneumonia are critical to reducing child mortality

Prevention and treatment of pneumonia are critical to reducing child mortality

FOCUS 1 and FOCUS 2 clinical trial results released

FOCUS 1 and FOCUS 2 clinical trial results released

Pneumonia-causing diseases kill 1.2m children under 5 annually, Studies say

Pneumonia-causing diseases kill 1.2m children under 5 annually, Studies say

New World Health Organization data emphasizes on two leading causes of pneumonia

New World Health Organization data emphasizes on two leading causes of pneumonia

Improving childhood immunization campaigns could reduce sickle-cell deaths in Africa, Study finds

Improving childhood immunization campaigns could reduce sickle-cell deaths in Africa, Study finds

Inspire Pharmaceuticals to increase production of azithromycin ophthalmic solution

Inspire Pharmaceuticals to increase production of azithromycin ophthalmic solution

Eye disease medication lowers death rate among Ethiopian children

Eye disease medication lowers death rate among Ethiopian children

The Gambia introduces pneumococcal immunisation programme

The Gambia introduces pneumococcal immunisation programme

New understanding on meningitis cause

New understanding on meningitis cause

Forest Labs and Astrazeneca to co-develop and commercialize ceftaroline

Forest Labs and Astrazeneca to co-develop and commercialize ceftaroline

Pneumococcal vaccine effective in preventing severe pneumonia

Pneumococcal vaccine effective in preventing severe pneumonia

Dangerous liaisons: bacterial 'sex' causes antibiotic resistance

Dangerous liaisons: bacterial 'sex' causes antibiotic resistance

GlaxoSmithKline opens pneumonia vaccine plant In Singapore

GlaxoSmithKline opens pneumonia vaccine plant In Singapore

Break through in the treatment of bacterial meningitis

Break through in the treatment of bacterial meningitis

Intercell starts trial for Streptococcus pneumoniae vaccine candidate

Intercell starts trial for Streptococcus pneumoniae vaccine candidate

Sagent Pharmaceuticals receives FDA approval of Azithromycin for injection

Sagent Pharmaceuticals receives FDA approval of Azithromycin for injection

FDA approves new indication for Wyeth's Tygacil (tigecycline)

FDA approves new indication for Wyeth's Tygacil (tigecycline)